Share Price and Basic Stock Data
Last Updated: December 13, 2025, 1:31 am
| PEG Ratio | 3.62 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Mazda Ltd, operating in the engineering sector, has demonstrated a notable trajectory in its revenue generation. For the financial year ending March 2025, the company’s sales stood at ₹193 Cr, marking a decline from the ₹225 Cr reported in the previous fiscal year. However, the trailing twelve-month sales of ₹207 Cr indicate a recovery trend, suggesting that the company is navigating through a challenging market landscape. The quarterly sales figures reveal fluctuations, with the highest sales recorded at ₹66.90 Cr in March 2023, followed by a dip to ₹36.17 Cr in June 2024. This volatility could raise concerns regarding demand stability, but it also highlights Mazda’s ability to recover, as seen in the ₹62.71 Cr sales for September 2023. The company’s operational agility will be crucial in maintaining this upward trajectory amidst a competitive environment.
Profitability and Efficiency Metrics
Mazda Ltd’s profitability indicators reflect a mixed performance, with the operating profit margin (OPM) dropping to 6.51% in the latest quarter. This decline is concerning when compared to a peak OPM of 22.62% in March 2023. The net profit for the same quarter was ₹4.91 Cr, which is lower than the ₹10.63 Cr reported in June 2022. The company’s return on equity (ROE) stands at 11.2%, which is relatively moderate, indicating that while the company is generating profits, it may not be maximising shareholder returns as effectively as its peers. Additionally, the interest coverage ratio at an impressive 69.84x suggests that Mazda is comfortably managing its financial obligations, with no borrowings reported. This financial prudence is a significant strength, allowing for continued operational investment without the burden of debt interest payments.
Balance Sheet Strength and Financial Ratios
The strength of Mazda Ltd’s balance sheet is underscored by its zero borrowings and substantial reserves of ₹231 Cr. This positions the company favorably in terms of financial stability and operational flexibility. The current ratio of 6.44x indicates a robust liquidity position, suggesting that Mazda can meet its short-term obligations comfortably. However, while the price-to-book value ratio stands at 2.14x, it may indicate that the stock is slightly overvalued relative to its book value, which could deter value-focused investors. The cash conversion cycle of 191 days also reflects some inefficiencies in managing working capital, particularly when compared to industry benchmarks. This metric warrants attention, as it could affect the company’s operational cash flow and overall liquidity if not addressed adequately.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Mazda Ltd reveals significant insights into investor confidence. The promoters hold 48.58% of the company, a stable figure that has seen marginal increases, reflecting their commitment to the business. However, foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold a mere 0.08% and 0.05%, respectively, suggesting a lack of interest from larger institutional players. This could be a double-edged sword; while the low institutional investment might imply a lack of confidence in growth potential, it could also present a buying opportunity for retail investors if the company can deliver on its operational promises. The public shareholding has increased to 51.29%, indicating growing retail interest, which could provide a cushion against market volatility.
Outlook, Risks, and Final Insight
Looking ahead, Mazda Ltd faces both opportunities and challenges. The company’s strong balance sheet and zero debt position provide a solid foundation to navigate potential economic headwinds. However, the recent decline in profitability metrics and fluctuating sales figures raise questions about sustainable growth. Investors should be cautious of the volatility in quarterly earnings, which may signal underlying operational challenges. Additionally, the lack of institutional interest could hinder price appreciation in the short term, even if the fundamentals improve. Ultimately, retail investors should consider whether Mazda’s current valuation reflects its operational potential and risk profile. The company’s ability to stabilize its sales and improve margins will be critical in determining its future as a viable investment in the engineering sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 209 Cr. | 613 | 1,086/541 | 16.6 | 218 | 0.49 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 23.6 Cr. | 78.5 | 112/58.9 | 19.4 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 6.40 Cr. | 14.8 | 17.7/9.31 | 1.25 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 8.01 Cr. | 13.0 | 16.0/10.3 | 4.68 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 56.9 Cr. | 0.61 | 7.14/0.48 | 6.84 | 1.27 | 0.00 % | 17.4 % | 16.4 % | 1.00 |
| Industry Average | 3,591.34 Cr | 456.12 | 51.17 | 119.01 | 0.29% | 37.74% | 16.87% | 6.04 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.53 | 51.77 | 43.31 | 66.90 | 51.19 | 62.71 | 53.97 | 57.55 | 36.17 | 56.79 | 46.78 | 53.52 | 49.63 |
| Expenses | 21.85 | 46.01 | 34.70 | 51.77 | 42.19 | 54.27 | 43.72 | 45.46 | 34.45 | 47.80 | 36.09 | 45.63 | 46.40 |
| Operating Profit | 7.68 | 5.76 | 8.61 | 15.13 | 9.00 | 8.44 | 10.25 | 12.09 | 1.72 | 8.99 | 10.69 | 7.89 | 3.23 |
| OPM % | 26.01% | 11.13% | 19.88% | 22.62% | 17.58% | 13.46% | 18.99% | 21.01% | 4.76% | 15.83% | 22.85% | 14.74% | 6.51% |
| Other Income | 0.07 | 0.63 | 1.02 | 0.61 | 1.85 | 1.00 | 1.77 | 1.96 | 3.14 | 3.88 | 0.20 | 0.92 | 4.27 |
| Interest | 0.18 | 0.19 | 0.10 | 0.16 | 0.19 | 0.10 | 0.11 | 0.15 | 0.15 | 0.07 | 0.21 | 0.10 | 0.16 |
| Depreciation | 0.46 | 0.83 | 0.91 | 0.95 | 1.00 | 1.00 | 1.00 | 1.02 | 0.96 | 0.97 | 0.98 | 0.98 | 1.02 |
| Profit before tax | 7.11 | 5.37 | 8.62 | 14.63 | 9.66 | 8.34 | 10.91 | 12.88 | 3.75 | 11.83 | 9.70 | 7.73 | 6.32 |
| Tax % | 22.93% | 27.19% | 23.32% | 27.41% | 20.39% | 25.78% | 24.20% | 27.25% | 22.93% | 24.09% | 23.51% | 28.07% | 22.31% |
| Net Profit | 5.50 | 3.90 | 6.61 | 10.63 | 7.70 | 6.19 | 8.26 | 9.37 | 2.90 | 8.98 | 7.42 | 5.56 | 4.91 |
| EPS in Rs | 2.75 | 1.95 | 3.30 | 5.32 | 3.85 | 3.10 | 4.13 | 4.68 | 1.45 | 4.49 | 3.71 | 2.78 | 2.45 |
Last Updated: August 20, 2025, 7:05 am
Below is a detailed analysis of the quarterly data for Mazda Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 49.63 Cr.. The value appears to be declining and may need further review. It has decreased from 53.52 Cr. (Mar 2025) to 49.63 Cr., marking a decrease of 3.89 Cr..
- For Expenses, as of Jun 2025, the value is 46.40 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 45.63 Cr. (Mar 2025) to 46.40 Cr., marking an increase of 0.77 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.23 Cr.. The value appears to be declining and may need further review. It has decreased from 7.89 Cr. (Mar 2025) to 3.23 Cr., marking a decrease of 4.66 Cr..
- For OPM %, as of Jun 2025, the value is 6.51%. The value appears to be declining and may need further review. It has decreased from 14.74% (Mar 2025) to 6.51%, marking a decrease of 8.23%.
- For Other Income, as of Jun 2025, the value is 4.27 Cr.. The value appears strong and on an upward trend. It has increased from 0.92 Cr. (Mar 2025) to 4.27 Cr., marking an increase of 3.35 Cr..
- For Interest, as of Jun 2025, the value is 0.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.10 Cr. (Mar 2025) to 0.16 Cr., marking an increase of 0.06 Cr..
- For Depreciation, as of Jun 2025, the value is 1.02 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.98 Cr. (Mar 2025) to 1.02 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Jun 2025, the value is 6.32 Cr.. The value appears to be declining and may need further review. It has decreased from 7.73 Cr. (Mar 2025) to 6.32 Cr., marking a decrease of 1.41 Cr..
- For Tax %, as of Jun 2025, the value is 22.31%. The value appears to be improving (decreasing) as expected. It has decreased from 28.07% (Mar 2025) to 22.31%, marking a decrease of 5.76%.
- For Net Profit, as of Jun 2025, the value is 4.91 Cr.. The value appears to be declining and may need further review. It has decreased from 5.56 Cr. (Mar 2025) to 4.91 Cr., marking a decrease of 0.65 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.45. The value appears to be declining and may need further review. It has decreased from 2.78 (Mar 2025) to 2.45, marking a decrease of 0.33.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:51 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 103 | 118 | 122 | 110 | 107 | 139 | 180 | 152 | 165 | 192 | 225 | 193 | 207 |
| Expenses | 87 | 101 | 104 | 97 | 93 | 120 | 155 | 129 | 137 | 154 | 186 | 163 | 176 |
| Operating Profit | 15 | 17 | 18 | 13 | 14 | 19 | 25 | 24 | 28 | 38 | 40 | 30 | 31 |
| OPM % | 15% | 15% | 15% | 12% | 13% | 14% | 14% | 16% | 17% | 20% | 18% | 16% | 15% |
| Other Income | 2 | 1 | 2 | 5 | 4 | 3 | 2 | 2 | 3 | 2 | 7 | 7 | 9 |
| Interest | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 4 | 4 | 4 |
| Profit before tax | 15 | 16 | 17 | 15 | 14 | 19 | 22 | 22 | 28 | 36 | 42 | 33 | 36 |
| Tax % | 31% | 30% | 29% | 14% | 29% | 24% | 26% | 26% | 23% | 25% | 25% | 25% | |
| Net Profit | 10 | 11 | 12 | 13 | 10 | 14 | 17 | 16 | 21 | 27 | 32 | 25 | 27 |
| EPS in Rs | 4.81 | 5.27 | 5.65 | 6.07 | 4.84 | 6.62 | 8.32 | 8.16 | 10.62 | 13.32 | 15.76 | 12.41 | 13.43 |
| Dividend Payout % | 23% | 23% | 23% | 24% | 34% | 27% | 24% | 27% | 23% | 21% | 20% | 29% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 10.00% | 9.09% | 8.33% | -23.08% | 40.00% | 21.43% | -5.88% | 31.25% | 28.57% | 18.52% | -21.88% |
| Change in YoY Net Profit Growth (%) | 0.00% | -0.91% | -0.76% | -31.41% | 63.08% | -18.57% | -27.31% | 37.13% | -2.68% | -10.05% | -40.39% |
Mazda Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 1% |
| 3 Years: | 5% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 8% |
| 3 Years: | 5% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 30% |
| 3 Years: | 34% |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 11% |
Last Updated: Unknown
Balance Sheet
Last Updated: December 4, 2025, 1:38 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | 79 | 87 | 95 | 114 | 120 | 130 | 128 | 143 | 160 | 182 | 208 | 226 | 231 |
| Borrowings | 4 | 3 | 2 | 2 | 3 | 2 | 1 | 1 | 0 | 1 | -0 | -0 | -0 |
| Other Liabilities | 29 | 29 | 31 | 20 | 24 | 37 | 34 | 24 | 28 | 38 | 28 | 35 | 52 |
| Total Liabilities | 116 | 123 | 132 | 141 | 151 | 173 | 167 | 173 | 192 | 224 | 240 | 265 | 287 |
| Fixed Assets | 20 | 21 | 23 | 34 | 34 | 34 | 33 | 35 | 35 | 76 | 75 | 74 | 75 |
| CWIP | 0 | 0 | 3 | 4 | 4 | 8 | 17 | 25 | 40 | 0 | -0 | 1 | 0 |
| Investments | 30 | 33 | 41 | 47 | 57 | 43 | 28 | 40 | 31 | 43 | 78 | 89 | 82 |
| Other Assets | 67 | 69 | 65 | 56 | 56 | 88 | 89 | 73 | 86 | 105 | 88 | 101 | 130 |
| Total Assets | 116 | 123 | 132 | 141 | 151 | 173 | 167 | 173 | 192 | 224 | 240 | 265 | 287 |
Below is a detailed analysis of the balance sheet data for Mazda Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Reserves, as of Sep 2025, the value is 231.00 Cr.. The value appears strong and on an upward trend. It has increased from 226.00 Cr. (Mar 2025) to 231.00 Cr., marking an increase of 5.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 52.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 35.00 Cr. (Mar 2025) to 52.00 Cr., marking an increase of 17.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 287.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 265.00 Cr. (Mar 2025) to 287.00 Cr., marking an increase of 22.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 74.00 Cr. (Mar 2025) to 75.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 82.00 Cr.. The value appears to be declining and may need further review. It has decreased from 89.00 Cr. (Mar 2025) to 82.00 Cr., marking a decrease of 7.00 Cr..
- For Other Assets, as of Sep 2025, the value is 130.00 Cr.. The value appears strong and on an upward trend. It has increased from 101.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 29.00 Cr..
- For Total Assets, as of Sep 2025, the value is 287.00 Cr.. The value appears strong and on an upward trend. It has increased from 265.00 Cr. (Mar 2025) to 287.00 Cr., marking an increase of 22.00 Cr..
Notably, the Reserves (231.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 11.00 | 14.00 | 16.00 | 11.00 | 11.00 | 17.00 | 24.00 | 23.00 | 28.00 | 37.00 | 40.00 | 30.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 78 | 70 | 68 | 75 | 85 | 79 | 67 | 76 | 92 | 70 | 54 | 77 |
| Inventory Days | 162 | 114 | 111 | 116 | 132 | 181 | 133 | 131 | 156 | 208 | 113 | 178 |
| Days Payable | 94 | 71 | 75 | 70 | 93 | 112 | 66 | 55 | 70 | 73 | 44 | 63 |
| Cash Conversion Cycle | 147 | 113 | 104 | 120 | 124 | 148 | 135 | 152 | 178 | 205 | 122 | 191 |
| Working Capital Days | 88 | 73 | 59 | 84 | 79 | 105 | 84 | 94 | 118 | 116 | 78 | 111 |
| ROCE % | 18% | 18% | 17% | 14% | 12% | 15% | 17% | 16% | 18% | 21% | 21% | 15% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 12.41 | 78.70 | 66.48 | 53.04 | 40.77 |
| Diluted EPS (Rs.) | 12.41 | 78.70 | 66.48 | 53.04 | 40.77 |
| Cash EPS (Rs.) | 14.35 | 88.73 | 74.36 | 59.08 | 48.93 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 114.82 | 529.94 | 464.18 | 409.56 | 368.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 114.82 | 529.94 | 464.18 | 409.56 | 368.11 |
| Dividend / Share (Rs.) | 3.60 | 16.00 | 14.00 | 12.10 | 11.00 |
| Revenue From Operations / Share (Rs.) | 96.51 | 562.87 | 478.20 | 411.97 | 380.58 |
| PBDIT / Share (Rs.) | 18.69 | 115.73 | 98.64 | 76.75 | 65.10 |
| PBIT / Share (Rs.) | 16.75 | 105.70 | 90.77 | 70.72 | 56.94 |
| PBT / Share (Rs.) | 16.48 | 104.34 | 89.19 | 69.04 | 55.16 |
| Net Profit / Share (Rs.) | 12.41 | 78.70 | 66.48 | 53.04 | 40.77 |
| PBDIT Margin (%) | 19.36 | 20.56 | 20.62 | 18.62 | 17.10 |
| PBIT Margin (%) | 17.35 | 18.77 | 18.98 | 17.16 | 14.95 |
| PBT Margin (%) | 17.07 | 18.53 | 18.65 | 16.75 | 14.49 |
| Net Profit Margin (%) | 12.86 | 13.98 | 13.90 | 12.87 | 10.71 |
| Return on Networth / Equity (%) | 10.80 | 14.85 | 14.32 | 12.95 | 11.07 |
| Return on Capital Employeed (%) | 14.20 | 19.52 | 19.11 | 17.01 | 15.19 |
| Return On Assets (%) | 9.38 | 13.10 | 11.87 | 11.08 | 9.43 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Asset Turnover Ratio (%) | 0.76 | 0.97 | 0.92 | 0.90 | 0.89 |
| Current Ratio (X) | 6.44 | 6.82 | 4.25 | 4.47 | 4.52 |
| Quick Ratio (X) | 4.91 | 5.30 | 2.70 | 3.10 | 3.26 |
| Inventory Turnover Ratio (X) | 4.85 | 2.24 | 2.46 | 2.67 | 2.25 |
| Dividend Payout Ratio (NP) (%) | 25.78 | 17.78 | 18.20 | 20.73 | 6.13 |
| Dividend Payout Ratio (CP) (%) | 22.29 | 15.77 | 16.27 | 18.61 | 5.10 |
| Earning Retention Ratio (%) | 74.22 | 82.22 | 81.80 | 79.27 | 93.87 |
| Cash Earning Retention Ratio (%) | 77.71 | 84.23 | 83.73 | 81.39 | 94.90 |
| Interest Coverage Ratio (X) | 69.84 | 85.23 | 62.77 | 45.72 | 36.62 |
| Interest Coverage Ratio (Post Tax) (X) | 47.38 | 58.96 | 43.30 | 32.60 | 23.94 |
| Enterprise Value (Cr.) | 482.67 | 500.35 | 240.03 | 192.88 | 173.22 |
| EV / Net Operating Revenue (X) | 2.50 | 2.22 | 1.25 | 1.17 | 1.14 |
| EV / EBITDA (X) | 12.90 | 10.80 | 6.08 | 6.28 | 6.64 |
| MarketCap / Net Operating Revenue (X) | 2.55 | 2.28 | 1.30 | 1.20 | 1.18 |
| Retention Ratios (%) | 74.21 | 82.21 | 81.79 | 79.26 | 93.86 |
| Price / BV (X) | 2.14 | 2.42 | 1.33 | 1.20 | 1.22 |
| Price / Net Operating Revenue (X) | 2.55 | 2.28 | 1.30 | 1.20 | 1.18 |
| EarningsYield | 0.05 | 0.06 | 0.10 | 0.10 | 0.09 |
After reviewing the key financial ratios for Mazda Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 2.00, marking a decrease of 8.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.41. This value is within the healthy range. It has decreased from 78.70 (Mar 24) to 12.41, marking a decrease of 66.29.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.41. This value is within the healthy range. It has decreased from 78.70 (Mar 24) to 12.41, marking a decrease of 66.29.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.35. This value is within the healthy range. It has decreased from 88.73 (Mar 24) to 14.35, marking a decrease of 74.38.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.82. It has decreased from 529.94 (Mar 24) to 114.82, marking a decrease of 415.12.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.82. It has decreased from 529.94 (Mar 24) to 114.82, marking a decrease of 415.12.
- For Dividend / Share (Rs.), as of Mar 25, the value is 3.60. This value exceeds the healthy maximum of 3. It has decreased from 16.00 (Mar 24) to 3.60, marking a decrease of 12.40.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 96.51. It has decreased from 562.87 (Mar 24) to 96.51, marking a decrease of 466.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 18.69. This value is within the healthy range. It has decreased from 115.73 (Mar 24) to 18.69, marking a decrease of 97.04.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.75. This value is within the healthy range. It has decreased from 105.70 (Mar 24) to 16.75, marking a decrease of 88.95.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.48. This value is within the healthy range. It has decreased from 104.34 (Mar 24) to 16.48, marking a decrease of 87.86.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.41. This value is within the healthy range. It has decreased from 78.70 (Mar 24) to 12.41, marking a decrease of 66.29.
- For PBDIT Margin (%), as of Mar 25, the value is 19.36. This value is within the healthy range. It has decreased from 20.56 (Mar 24) to 19.36, marking a decrease of 1.20.
- For PBIT Margin (%), as of Mar 25, the value is 17.35. This value is within the healthy range. It has decreased from 18.77 (Mar 24) to 17.35, marking a decrease of 1.42.
- For PBT Margin (%), as of Mar 25, the value is 17.07. This value is within the healthy range. It has decreased from 18.53 (Mar 24) to 17.07, marking a decrease of 1.46.
- For Net Profit Margin (%), as of Mar 25, the value is 12.86. This value exceeds the healthy maximum of 10. It has decreased from 13.98 (Mar 24) to 12.86, marking a decrease of 1.12.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.80. This value is below the healthy minimum of 15. It has decreased from 14.85 (Mar 24) to 10.80, marking a decrease of 4.05.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.20. This value is within the healthy range. It has decreased from 19.52 (Mar 24) to 14.20, marking a decrease of 5.32.
- For Return On Assets (%), as of Mar 25, the value is 9.38. This value is within the healthy range. It has decreased from 13.10 (Mar 24) to 9.38, marking a decrease of 3.72.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.76. It has decreased from 0.97 (Mar 24) to 0.76, marking a decrease of 0.21.
- For Current Ratio (X), as of Mar 25, the value is 6.44. This value exceeds the healthy maximum of 3. It has decreased from 6.82 (Mar 24) to 6.44, marking a decrease of 0.38.
- For Quick Ratio (X), as of Mar 25, the value is 4.91. This value exceeds the healthy maximum of 2. It has decreased from 5.30 (Mar 24) to 4.91, marking a decrease of 0.39.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.85. This value is within the healthy range. It has increased from 2.24 (Mar 24) to 4.85, marking an increase of 2.61.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 25.78. This value is within the healthy range. It has increased from 17.78 (Mar 24) to 25.78, marking an increase of 8.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 22.29. This value is within the healthy range. It has increased from 15.77 (Mar 24) to 22.29, marking an increase of 6.52.
- For Earning Retention Ratio (%), as of Mar 25, the value is 74.22. This value exceeds the healthy maximum of 70. It has decreased from 82.22 (Mar 24) to 74.22, marking a decrease of 8.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 77.71. This value exceeds the healthy maximum of 70. It has decreased from 84.23 (Mar 24) to 77.71, marking a decrease of 6.52.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 69.84. This value is within the healthy range. It has decreased from 85.23 (Mar 24) to 69.84, marking a decrease of 15.39.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 47.38. This value is within the healthy range. It has decreased from 58.96 (Mar 24) to 47.38, marking a decrease of 11.58.
- For Enterprise Value (Cr.), as of Mar 25, the value is 482.67. It has decreased from 500.35 (Mar 24) to 482.67, marking a decrease of 17.68.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.50. This value is within the healthy range. It has increased from 2.22 (Mar 24) to 2.50, marking an increase of 0.28.
- For EV / EBITDA (X), as of Mar 25, the value is 12.90. This value is within the healthy range. It has increased from 10.80 (Mar 24) to 12.90, marking an increase of 2.10.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.55. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.55, marking an increase of 0.27.
- For Retention Ratios (%), as of Mar 25, the value is 74.21. This value exceeds the healthy maximum of 70. It has decreased from 82.21 (Mar 24) to 74.21, marking a decrease of 8.00.
- For Price / BV (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has decreased from 2.42 (Mar 24) to 2.14, marking a decrease of 0.28.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.55. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.55, marking an increase of 0.27.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mazda Ltd:
- Net Profit Margin: 12.86%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.2% (Industry Average ROCE: 35.65%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.8% (Industry Average ROE: 14.37%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 47.38
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.91
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 17.4 (Industry average Stock P/E: 38.85)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.86%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | C/1-39/13/16, GIDC, Ahmedabad Gujarat 382330 | info@mazdalimited.com http://www.mazdalimited.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mohib N Khericha | Chairman |
| Mr. Percy X Avari | Whole Time Director |
| Mrs. Shanaya Mody Khatua | Whole Time Director |
| Mr. Samuel W Croll- III | Director |
| Mrs. Sheila S Mody | Director |
| Mrs. Houtoxi F Contractor | Director |
| Mr. Mihir Mehta | Director |
| Mr. Ashok Kavdia | Director |
| Mrs. Shetal Bhatt | Director |
FAQ
What is the intrinsic value of Mazda Ltd?
Mazda Ltd's intrinsic value (as of 12 December 2025) is 185.38 which is 16.12% lower the current market price of 221.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 443 Cr. market cap, FY2025-2026 high/low of 429/205, reserves of ₹231 Cr, and liabilities of 287 Cr.
What is the Market Cap of Mazda Ltd?
The Market Cap of Mazda Ltd is 443 Cr..
What is the current Stock Price of Mazda Ltd as on 12 December 2025?
The current stock price of Mazda Ltd as on 12 December 2025 is 221.
What is the High / Low of Mazda Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mazda Ltd stocks is 429/205.
What is the Stock P/E of Mazda Ltd?
The Stock P/E of Mazda Ltd is 17.4.
What is the Book Value of Mazda Ltd?
The Book Value of Mazda Ltd is 117.
What is the Dividend Yield of Mazda Ltd?
The Dividend Yield of Mazda Ltd is 1.63 %.
What is the ROCE of Mazda Ltd?
The ROCE of Mazda Ltd is 15.2 %.
What is the ROE of Mazda Ltd?
The ROE of Mazda Ltd is 11.2 %.
What is the Face Value of Mazda Ltd?
The Face Value of Mazda Ltd is 2.00.